Publications by Marit Synnestvedt
37 publications found
Original articles
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
Mol Oncol, 15 (4), 957-967
DOI 10.1002/1878-0261.12865, PubMed 33252186
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
Breast Cancer Res, 20 (1), 120
DOI 10.1186/s13058-018-1049-0, PubMed 30322396
Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone
Clin Radiol, 72 (7), 573-579
DOI 10.1016/j.crad.2017.02.013, PubMed 28318506
Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
Breast Cancer Res Treat, 162 (1), 127-137
DOI 10.1007/s10549-016-4096-1, PubMed 28058579
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer
J Clin Oncol, 32 (34), 3848-57
DOI 10.1200/JCO.2014.56.9327, PubMed 25366688
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
BMC Cancer, 14, 514
DOI 10.1186/1471-2407-14-514, PubMed 25023626
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
Breast Cancer Res Treat, 138 (2), 485-97
DOI 10.1007/s10549-013-2439-8, PubMed 23456230
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
BMC Cancer, 12, 616
DOI 10.1186/1471-2407-12-616, PubMed 23259667
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol Histopathol, 27 (10), 1315-25
DOI 10.14670/HH-27.1315, PubMed 22936450
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
Acta Oncol, 52 (1), 91-101
DOI 10.3109/0284186X.2012.713508, PubMed 22934555
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-64
DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
Breast Cancer Res, 13 (3), R61
DOI 10.1186/bcr2898, PubMed 21672237
Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
Clin Cancer Res, 17 (9), 2967-76
DOI 10.1158/1078-0432.CCR-10-2515, PubMed 21415211
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
Mol Oncol, 5 (1), 77-92
DOI 10.1016/j.molonc.2010.11.002, PubMed 21169070
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Breast Cancer Res Treat, 125 (3), 729-38
DOI 10.1007/s10549-010-0911-2, PubMed 20449649
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
Histol Histopathol, 24 (8), 1049-59
DOI 10.14670/HH-24.1049, PubMed 19554512
The prognostic impact of occult nodal metastasis in early breast carcinoma
Breast Cancer Res Treat, 118 (1), 57-66
DOI 10.1007/s10549-009-0340-2, PubMed 19219629
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
Clin Cancer Res, 14 (8), 2341-50
DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
Mol Oncol, 1 (2), 160-71
DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292
Recurrent group A Streptococcal genital infection after Puerperal sepsis
Scand J Infect Dis, 35 (8), 509-10
DOI 10.1080/00365540310013261, PubMed 14514155
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study
Ann Plast Surg, 46 (5), 488-94
DOI 10.1097/00000637-200105000-00006, PubMed 11352421
Signs and symptoms of melanoma in older populations
J Clin Epidemiol, 53 (10), 1044-53
DOI 10.1016/s0895-4356(00)00224-9, PubMed 11027938
Hormonal influences on women with psoriasis
Cutis, 61 (5), 257-60
PubMed 9608337
[Colorectal cancer. Location dependent symptoms?]
Tidsskr Nor Laegeforen, 117 (26), 3796-9
PubMed 9417683
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group
Cancer, 79 (9), 1816-21
DOI 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-#, PubMed 9129001
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group
Ann Intern Med, 125 (5), 369-75
DOI 10.7326/0003-4819-125-5-199609010-00003, PubMed 8702087
Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma
Cancer, 76 (11), 2242-7
DOI 10.1002/1097-0142(19951201)76:11<2242::aid-cncr2820761110>3.0.co;2-i, PubMed 8635027
Dysplastic nevi as a melanoma risk factor in patients with familial melanoma
Cancer, 74 (12), 3118-25
DOI 10.1002/1097-0142(19941215)74:12<3118::aid-cncr2820741210>3.0.co;2-7, PubMed 7982177
Natural history of dysplastic nevi
J Am Acad Dermatol, 29 (1), 51-7
DOI 10.1016/0190-9622(93)70151-i, PubMed 8315078
A cohort study of melanoma in patients with dysplastic nevi
J Invest Dermatol, 100 (3), 346S-349S
DOI 10.1111/1523-1747.ep12470256, PubMed 8440922
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent
J Invest Dermatol, 100 (3), 342S-345S
DOI 10.1111/1523-1747.ep12470248, PubMed 8440920
Loco-regional nodal relapse in melanoma
Surg Oncol, 1 (5), 333-40
DOI 10.1016/0960-7404(92)90033-h, PubMed 1341268
The prognostic implications of microscopic satellites in patients with clinical stage I melanoma
Arch Surg, 126 (12), 1461-8
DOI 10.1001/archsurg.1991.01410360031006, PubMed 1842174
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study
Arch Dermatol, 127 (7), 995-9
PubMed 2064418
Model predicting survival in stage I melanoma based on tumor progression
J Natl Cancer Inst, 81 (24), 1893-904
DOI 10.1093/jnci/81.24.1893, PubMed 2593166
A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas
Plast Reconstr Surg, 81 (5), 688-93
DOI 10.1097/00006534-198805000-00007, PubMed 3362987
Other articles
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
Mol. Oncol., 4 (2), 169
DOI 10.1016/j.molonc.2010.01.003